Related Experiment Video
Updated: Oct 30, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Characteristics and Survival of Intensive Care Unit Patients with Coronavirus Disease in Osaka, Japan: A
Ling Zha1, Tomotaka Sobue1, Taro Takeuchi1
1Environmental Medicine and Population Sciences, Department of Social Medicine, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita 565-0871, Japan.
Insights
This study analyzed 205 intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19) in Japan. Older age, particularly over 80, significantly increased mortality risk in ICU patients with COVID-19.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Epidemiology
Background:
- Limited data exists on the intensive care unit (ICU) management and outcomes for coronavirus disease 2019 (COVID-19) patients in Japan.
- Understanding the characteristics of severe COVID-19 cases is crucial for optimizing treatment strategies.
Purpose of the Study:
- To evaluate the epidemiological and clinical features, treatments, and outcomes of COVID-19 patients admitted to ICUs in Osaka Prefecture, Japan.
- To identify factors associated with mortality in this patient cohort.
Main Methods:
- Analysis of registry data from 205 COVID-19 ICU patients admitted between February and November 2020.
- Utilized a Cox proportional hazards model to assess mortality risk factors.
- Follow-up data on patient outcomes at discharge.
Main Results:
- The majority of ICU patients were male (78.5%) and over 60 years old (72.7%).
- Comorbidities were present in 57.1% of patients; 91.2% required mechanical ventilation, and 15.6% needed extracorporeal membrane oxygenation.
- Mortality rate was 28.3%; patients over 80 years old had a significantly higher hazard ratio for mortality (6.02) compared to those ≤59 years old.
Conclusions:
- The study highlights the significant impact of age, particularly advanced age, on mortality risk in severe COVID-19 patients requiring ICU care.
- Findings provide valuable insights into the clinical course and prognosis of COVID-19 in Japanese ICU settings.
- Data can inform clinical decision-making and resource allocation for severe COVID-19 cases.
Abstract:
The epidemiological and clinical characteristics, treatments, and outcomes of patients with coronavirus disease 2019 (COVID-19) who are admitted to the intensive care unit (ICU) have not been adequately evaluated in Japan. We analyzed the registry data of 205 patients with COVID-19 admitted to the ICU between February and November 2020, in Osaka Prefecture, Japan. A Cox proportional hazards model was used to assess the association between epidemiological factors and mortality among ICU patients. Of the 205 ICU patients, 161 (78.5%) were men and 149 (72.7%) were older than 60 years. A total of 117 patients (57.1%) had comorbidities. The most common symptoms at diagnosis were mild (n = 131, 63.9%). A total of 187 patients (91.2%) received mechanical ventilation, and 32 patients (15.6%) required extracorporeal membrane oxygenation. Patients were followed up for a median of 25 days after ICU admission. A total of 147 patients (71.7%) were alive at discharge, and 58 patients (28.3%) died. The hazard ratio for mortality among patients aged >80 years was 6.02 (95% confidence interval: 2.10-17.25) in the multivariable model, which was higher than that among those aged ≤59 years. These results are useful for recognizing the clinical course of this infection in ICU patients.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia III: Complications and Assessment

